Collegium Pharmaceutical, Inc (COLL): Share Repurchases
$25.10M
Year ended 2025-12-31
+21.3%
3-year compound annual growth
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $25.10M | -58.2% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $60.02M | -20.0% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $75.00M | +433.3% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $14.06M | -70.6% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $47.86M | n/a | 2024-02-22, From 2021-01-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $25.10M | -58.2% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $172.91M | n/m |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $24.90M | n/a |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $148.33M | +493.3% |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $75.59M | -11.6% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $12.21M | +11.4% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $47.04M | -47.9% |
| Organogenesis Holdings Inc. (ORGO) | 2024-12-31 | $25.48M | n/a |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $156.28M | +203.4% |
Compare COLL, CORT, EBS, PCRX side by side · Screen every company in Pharmaceutical Preparations ↗